Corporate Members

The MBI encourages involvement from those in private industry. The Institute offers incentives to pharmaceutical and bioengineering companies interested in becoming a Corporate Member.

Membership benefits include:

• regular visits by MBI Directors to identify problems and topics of interest, where mathematical sciences could be helpful;
• follow-up to these problems by Institute Researchers; and
• invitation to present industrial challenges and problems to MBI audiences and to participate in MBI programs and workshops.
  
  

Current Corporate Members:

Pfizer
GlaxoSmithKline